 **Michael Tu, Ph.D.**
                        
Experience
===================================================

2020-Present
: *Chief Scientific Officer at Liquid Diagnostics LLC*
: San Clemente, CA

2017‚Äì2021
: *Director of R&D at EZLife Bio Inc*
: Los Angeles, CA

2015‚Äì2017
: *T90 Postdoctoral Scholar at UCLA*
: (Los Angeles, CA)

2012‚Äì2015
: *T32 Predoctoral Scholar at UCLA*
: (Los Angeles, CA)

2011
: *Consultant at Evidia Biosciences *
: (Diamond Bar, CA)


2009-2012
: *Teacher's Assistant at UCLA Engineering *
: (Los Angeles, CA)


Summer 2008
: *Intern at Genefluidics *
: (Los Angeles, CA)



Education
===================================================================

Ph.D. (2015)
: *UCLA* Biomedical Engineering


M.S. (2010)
: *UCLA* Biomedical Engineering


B.S. (2009)
: *UCLA* Bioengineering


Select Publications
===================================================================

- M. K. Tu, et al. ‚ÄúThe Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population,‚Äù J.I., p. ji2100919, Jan. 2022, doi: 10.4049/jimmunol.2100919.
- S. H. Chiang, M.Tu, et al., ‚ÄúDevelopment and validation of a quantitative, non-invasive, highly sensitive and specific, electrochemical assay for anti-SARS-CoV-2 IgG antibodies in saliva,‚Äù PLoS ONE, vol. 16, no. 7, p. e0251342, Jul. 2021, doi: 10.1371/journal.pone.0251342.
- M. Tu et al., ‚ÄúRapid PCR-Free Meat Species Identification using Electric Field Induced Release and Measurement (EFIRM¬Æ),‚Äù Analytica Chimica Acta, p. S000326701931414X, Nov. 2019, doi: 10.1016/j.aca.2019.11.051.
- M. Tu et al., ‚ÄúElectric Field Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva,‚Äù The Journal of Molecular Diagnostics, p. S1525157820303500, Jun. 2020, doi: 10.1016/j.jmoldx.2020.05.005.
- M. Tu, D. Chia, F. Wei, and D. Wong, ‚ÄúLiquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB),‚Äù The Analyst, 2016, doi: 10.1039/C5AN01863C.
- M. Suh et al., ‚ÄúA Remote Patient Monitoring System for Congestive Heart Failure,‚Äù Journal of Medical Systems, vol. 35, no. 5, pp. 1165‚Äì1179, May 2011, doi: 10.1007/s10916-011-9733-y.
- [Full listüìÉ](https://orcid.org/0000-0002-7227-4030)

<style>dt { width: 110px; font-family: arial} dd { padding-bottom: 1px } 
.md h1:before, .md h2:before { content: none }
.md ul li.plus { list-style-type: none; margin-left: -40px; padding-bottom: 10px}
.md table.table { margin-left: -15px; padding-bottom: 20px }
.md table.table tr { vertical-align: top }
.md table.table th { color: #000; background: none; border: none; padding-bottom: 2px }
.md table.table tr:nth-child(even) { background: none }
.md table.table td { background: none; border: none; padding-bottom: 0px; padding-top: 2px }
.md table {page-break-inside: auto}
em.asterisk { font-style: normal; font-weight: bold }</style>
<script>markdeepOptions = {definitionStyle:'short', tocStyle:'none'}</script>

<!-- Markdeep: --><style class="fallback">body{visibility:hidden;white-space:pre;font-family:monospace}</style><script src="markdeep.min.js"></script><script src="https://casual-effects.com/markdeep/latest/markdeep.min.js?"></script><script>window.alreadyProcessedMarkdeep||(document.body.style.visibility="visible")</script>
